CAS 82543-16-6

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Virtual Booth

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

CHEMISTRY

Discover Molecule Insights

BUILDING BLOCK

3 Suppliers, 3 End Use APIs, 6 Related Intermediates

3 Suppliers
3 End Use APIs
6 Related Intermediates

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 82543-16-6, 3b,5b-dihydroxy-6b,7b,15b,16b-dimethylene-5b-androst-17-one, 3beta,5-dihydroxy-6beta,7beta;15beta,16beta-dimethylene-5beta-androstan-17-one, (1r,2r,4r,5r,7s,10r,11s,14s,16s,18s,19s)-5,7-dihydroxy-10,14-dimethylhexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecan-15-one, 6beta,7beta,15beta,16beta-dimethylene-3beta,5beta-dihydroxyandrostan-17-one, (2s,4ar,4bs,6as,7as,8as,8bs,8cr,8dr,9ar,9br)-2,9b-dihydroxy-4a,6a-dimethylhexadecahydro-1h-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthren-7(7ah)-one

Molecular Formula

C₂₁H₃₀O₃

Molecular Weight

330.5 g/mol

InChI Key

GWUFXQIQXPASJU-VJWUOOCFSA-N

1 2D Structure

CAS 82543-16-6

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(1R,2R,4R,5R,7S,10R,11S,14S,16S,18S,19S)-5,7-dihydroxy-10,14-dimethylhexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecan-15-one

2.1.2 InChI

InChI=1S/C21H30O3/c1-19-5-4-14-16(17(19)11-7-12(11)18(19)23)13-8-15(13)21(24)9-10(22)3-6-20(14,21)2/h10-17,22,24H,3-9H2,1-2H3/t10-,11+,12-,13-,14-,15+,16+,17-,19-,20+,21+/m0/s1

2.1.3 InChI Key

GWUFXQIQXPASJU-VJWUOOCFSA-N

2.1.4 Canonical SMILES

CC12CCC(CC1(C3CC3C4C2CCC5(C4C6CC6C5=O)C)O)O

2.1.5 Isomeric SMILES

C[C@]12CC[C@@H](C[C@]1([C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6C5=O)C)O)O

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 82543-16-6

2. 3b,5b-dihydroxy-6b,7b,15b,16b-dimethylene-5b-androst-17-one

3. 3beta,5-dihydroxy-6beta,7beta;15beta,16beta-dimethylene-5beta-androstan-17-one

4. (1r,2r,4r,5r,7s,10r,11s,14s,16s,18s,19s)-5,7-dihydroxy-10,14-dimethylhexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecan-15-one

5. 6beta,7beta,15beta,16beta-dimethylene-3beta,5beta-dihydroxyandrostan-17-one

6. (2s,4ar,4bs,6as,7as,8as,8bs,8cr,8dr,9ar,9br)-2,9b-dihydroxy-4a,6a-dimethylhexadecahydro-1h-cyclopropa[4,5]cyclopenta[1,2-a]cyclopropa[l]phenanthren-7(7ah)-one

7. Ec 617-347-4

8. Schembl13936420

9. Mfcd09952196

10. Zinc72399748

11. Akos025311213

12. (3s,5r,6r,7r,8r,9s,10r,13s,14s,15s, 16s)-octadecahydro-3,5-dihydroxy-10,13-dimethyl-17h-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthren-17-one

13. Ac-28721

14. As-13047

15. C76643

16. 543d166

17. Q-102812

18. 3?,5?-dihydroxy-6?,7?;15?,16?-dimethylene-androst-17-one

19. 6?,7?,15?,16?-dimethylene-3?,5?-dihydroxyandrostan-17-one

20. 7b-hydroxy-15b,16b-methylene-3b-pivaloyloxy-5 Androsten-17-one

21. 6

22. A,7

23. A,15

24. A,16

25. A-dimethylene-3

26. A,5

27. A-dihydroxyandrostan-17-one

28. 3beta,5-dihydroxy-6beta,7beta:15beta,16beta-dimethylene-5beta-androstane-17-one

29. 3beta,5-dihydroxy-6beta,7beta15beta,16beta-dimethylene-5beta-androstan-17-one

30. (2s,4ar,4bs,6as,7as,9as,9br,9cr,11as)-2,11a-dihydroxy-4a,6a-dimethyloctadecahydro-7h-cyclobuta[4,5]cyclopenta[1,2-a]phenanthren-7-on E

2.3 Create Date

2007-02-08

3 Chemical and Physical Properties

Molecular Formula	C₂₁H₃₀O₃
Molecular Weight	330.5 g/mol
XLogP3	2.4
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	0
Exact Mass	330.21949481 g/mol
Monoisotopic Mass	330.21949481 g/mol
Topological Polar Surface Area	57.5 Å²
Heavy Atom Count	24
Formal Charge	0
Complexity	645
Isotope Atom Count	0
Defined Atom Stereocenter Count	11
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1